- BSc, Chemistry, Universidad Nacional Autónoma de México, 2005
- MSc, Chemical Sciences, Universidad Nacional Autónoma de México, 2007
- PhD, Medicinal Inorganic Chemistry, University of Warwick, 2010
Media[/vc_column][vc_column fade_animation_offset=”45px” width=”1/2″]
Soledad Betanzos-Lara received her BSc (Chemistry, Honours) and MSc (Chemical Sciences) degrees from the Universidad Nacional Autónoma de México (UNAM). In 2006, she travelled to the Queen’s University of Belfast as a Visiting Research Associate to collaborate with Dr. M. Cristina Lagunas investigating the optical behaviour of metal-based molecules as cation probes.
For her PhD (Medicinal Inorganic Chemistry), Soledad joined Prof. Peter J. Sadler’s group at the University of Warwick (UK) in 2007. Teaming up with Dr. Abraha Habtemariam, she worked in the field of pre-clinical bio-organometallic chemistry to develop a new class of photoactivatable pro-drugs for cancer treatment and discovered novel metal-enzyme biomimetic interactions that are critical for the electrochemical balance in cells.
In 2011, Soledad re-joined her Alma Mater (UNAM) as a postdoctoral fellow within Prof. Noráh Barba-Behrens group, where she established a family of highly-cytotoxic metal-based drugs and introduced innovative molecular biology and microscopy methods to investigate their mechanism of action. More recently, as a systematic reviewer at a private consulting agency, she has been drafting research protocols for Novartis, Sanofi Laboratories, and Merck Sharp & Dohme.[/vc_column][/vc_row]